Samsrita Labs Limited , a company listed on BSE Limited and Metropolitan Stock Exchange of India Limited, has seen a significant change in its shareholding structure. Four members of the Basaboini family have acquired a combined 6.6% stake in the company through a preferential allotment on July 18, 2025.

Details of the Acquisition

The preferential allotment involved the following acquisitions:

The acquisition was made on a cash basis through the preferential issue. It's worth noting that the acquirers did not belong to the promoter group and had no previous holdings in the company.

Impact on Share Capital

Following this acquisition, Samsrita Labs' total equity share capital has increased significantly:

• Before Acquisition: 1,48,08,706 equity shares of Rs. 10 each
• After Acquisition: 2,27,49,710 equity shares of Rs. 10 each

This represents an increase of 79,41,004 shares, or approximately 53.6% in the total number of outstanding shares.

Regulatory Compliance

In compliance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the acquirers have filed the necessary disclosures under Regulation 29(1). These disclosures were submitted to both BSE Limited and Metropolitan Stock Exchange of India Limited on July 21, 2025.

Company Background

Samsrita Labs Limited is headquartered at 6-3-354/13/B2, Flat.No.B2, Suryateja Apartments, Hindi Nagar, Punjagutta, Hyderabad-500082, Telangana, India. The company's shares are listed on both BSE Limited and Metropolitan Stock Exchange of India Limited.

This preferential allotment and the resulting change in shareholding structure could potentially impact the company's governance and strategic direction. Investors and market watchers will likely be keen to observe any subsequent changes in the company's operations or performance following this significant acquisition.

Samsrita Labs Limited , a company listed on the Metropolitan Stock Exchange of India Limited, has witnessed a significant change in its shareholding structure. Perla Naga Pattabhi Ravikanth, an individual investor, has acquired a substantial stake in the company through a preferential allotment on a swap basis.

Key Details of the Acquisition

Impact on Shareholding

The acquisition has triggered disclosure requirements under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. According to the disclosure:

Company Details

Additional Information

• The acquirer, Perla Naga Pattabhi Ravikanth, does not belong to the promoter or promoter group of Samsrita Labs Limited.
• The shares were allotted on July 18, 2025, and the disclosure was filed on July 21, 2025, in compliance with SEBI regulations.
• This preferential allotment was conducted on a swap basis, indicating that the shares were issued in exchange for some other consideration, possibly assets or shares of another entity.

The acquisition represents a significant development for Samsrita Labs Limited, potentially influencing the company's ownership structure and future strategic decisions. Investors and market participants will likely monitor any further developments or changes in the company's direction following this substantial stake acquisition.